D B Rifkin

4.3k total citations · 1 hit paper
26 papers, 3.7k citations indexed

About

D B Rifkin is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, D B Rifkin has authored 26 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Hematology. Recurrent topics in D B Rifkin's work include Protease and Inhibitor Mechanisms (10 papers), Fibroblast Growth Factor Research (8 papers) and Proteoglycans and glycosaminoglycans research (5 papers). D B Rifkin is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Fibroblast Growth Factor Research (8 papers) and Proteoglycans and glycosaminoglycans research (5 papers). D B Rifkin collaborates with scholars based in United States, Italy and Canada. D B Rifkin's co-authors include David Moscatelli, Phillip A. Dennis, Marco Presta, Paolo Mignatti, Mayumi Abé, David J. Loskutoff, John G. Harpel, Irene Nunes, Christine N. Metz and Jacquelyn Joseph‐Silverstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The Journal of Cell Biology.

In The Last Decade

D B Rifkin

25 papers receiving 3.5k citations

Hit Papers

An Assay for Transforming Growth Factor-β Using Cells Tra... 1994 2026 2004 2015 1994 200 400 600

Peers

D B Rifkin
Patrice Tremble United States
Russette M. Lyons United States
L A Liotta United States
Joachim Sasse United States
Sela Cheifetz United States
Patrice Tremble United States
D B Rifkin
Citations per year, relative to D B Rifkin D B Rifkin (= 1×) peers Patrice Tremble

Countries citing papers authored by D B Rifkin

Since Specialization
Citations

This map shows the geographic impact of D B Rifkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D B Rifkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D B Rifkin more than expected).

Fields of papers citing papers by D B Rifkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D B Rifkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D B Rifkin. The network helps show where D B Rifkin may publish in the future.

Co-authorship network of co-authors of D B Rifkin

This figure shows the co-authorship network connecting the top 25 collaborators of D B Rifkin. A scholar is included among the top collaborators of D B Rifkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D B Rifkin. D B Rifkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Topp, William C., Jennifer Hall, Margery P. F. Marsden, et al.. (2024). In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells. PubMed. 36(11 Pt. 2). 4217–23.
2.
Dabovic, Branka, et al.. (2002). Bone defects in latent TGF-beta binding protein (Ltbp)-3 null mice; a role for Ltbp in TGF-beta presentation. Journal of Endocrinology. 175(1). 129–141. 59 indexed citations
3.
Mignatti, Paolo & D B Rifkin. (1996). Plasminogen Activators and MatrixMetalloproteinases in Angiogenesis. PubMed. 49(1-3). 117–137. 276 indexed citations
4.
Abé, Mayumi, John G. Harpel, Christine N. Metz, et al.. (1994). An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Construct. Analytical Biochemistry. 216(2). 276–284. 677 indexed citations breakdown →
6.
Brunner, Georg, et al.. (1993). Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood. 81(3). 631–638. 9 indexed citations
7.
Dennis, Phillip A. & D B Rifkin. (1991). Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.. Proceedings of the National Academy of Sciences. 88(2). 580–584. 435 indexed citations
8.
Kojima, Soichi, P C Harpel, & D B Rifkin. (1991). Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration.. The Journal of Cell Biology. 113(6). 1439–1445. 202 indexed citations
9.
Quarto, Natalina, Daniela Talarico, Robert Z. Florkiewicz, & D B Rifkin. (1991). Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells.. PubMed. 2(9). 699–708. 94 indexed citations
10.
Wilson, EL, et al.. (1991). Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood. 77(5). 954–960. 7 indexed citations
11.
Rifkin, D B, Ryoji Tsuboi, & Paolo Mignatti. (1989). The Role of Proteases in Matrix Breakdown during Cellular Invasion. American Review of Respiratory Disease. 140(4). 1112–1113. 12 indexed citations
12.
Broadley, Kenneth N., Antonio M. Aquino, Stephen Woodward, et al.. (1989). Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair.. PubMed. 61(5). 571–5. 161 indexed citations
13.
Mira-y-Lopez, Rafael, Jacquelyn Joseph‐Silverstein, D B Rifkin, & Liliana Ossowski. (1986). Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells.. Proceedings of the National Academy of Sciences. 83(20). 7780–7784. 23 indexed citations
14.
Presta, Marco, David Moscatelli, Jacquelyn Joseph‐Silverstein, & D B Rifkin. (1986). Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration.. Molecular and Cellular Biology. 6(11). 4060–4066. 238 indexed citations
15.
Gross, Janet L., David Moscatelli, & D B Rifkin. (1983). Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro.. Proceedings of the National Academy of Sciences. 80(9). 2623–2627. 216 indexed citations
16.
Gross, JL, Michael N. Krupp, D B Rifkin, & M. Daniel Lane. (1983). Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells.. Proceedings of the National Academy of Sciences. 80(8). 2276–2280. 63 indexed citations
17.
Rifkin, D B, et al.. (1982). Binding of developing mouse cerebellar cells to fibronectin: a possible mechanism for the formation of the external granular layer. Journal of Neuroscience. 2(9). 1195–1206. 75 indexed citations
18.
Gross, JL, David Moscatelli, EA Jaffe, & D B Rifkin. (1982). Plasminogen activator and collagenase production by cultured capillary endothelial cells. The Journal of Cell Biology. 95(3). 974–981. 239 indexed citations
19.
Hassell, John A., et al.. (1980). Transformation of rat embryo fibroblasts by cloned polyoma virus DNA fragments containing only part of the early region.. Proceedings of the National Academy of Sciences. 77(7). 3978–3982. 65 indexed citations
20.
Rifkin, D B, et al.. (1977). Patterns of plasminogen activator production in cultured normal embryonic cells.. The Journal of Cell Biology. 75(1). 31–42. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026